|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 19481 |
FusionGeneSummary for LARP4_RYR3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LARP4_RYR3 | Fusion gene ID: 19481 | Hgene | Tgene | Gene symbol | LARP4 | RYR3 | Gene ID | 113251 | 6263 |
| Gene name | La ribonucleoprotein domain family member 4 | ryanodine receptor 3 | |
| Synonyms | PP13296 | RYR-3 | |
| Cytomap | 12q13.12 | 15q13.3-q14 | |
| Type of gene | protein-coding | protein-coding | |
| Description | la-related protein 4c-Mpl binding protein | ryanodine receptor 3brain ryanodine receptor-calcium release channelbrain-type ryanodine receptortype 3 ryanodine receptor | |
| Modification date | 20180527 | 20180523 | |
| UniProtAcc | Q71RC2 | Q15413 | |
| Ensembl transtripts involved in fusion gene | ENST00000293618, ENST00000429001, ENST00000398473, ENST00000518444, ENST00000347328, ENST00000522085, ENST00000518561, | ENST00000415757, ENST00000389232, ENST00000559917, | |
| Fusion gene scores | * DoF score | 8 X 4 X 6=192 | 3 X 3 X 3=27 |
| # samples | 8 | 3 | |
| ** MAII score | log2(8/192*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: LARP4 [Title/Abstract] AND RYR3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | BRCA | TCGA-BH-A5IZ-01A | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000293618 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000293618 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5CDS-intron | ENST00000293618 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000429001 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000429001 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5CDS-intron | ENST00000429001 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000398473 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000398473 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5CDS-intron | ENST00000398473 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000518444 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000518444 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5CDS-intron | ENST00000518444 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000347328 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000347328 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5CDS-intron | ENST00000347328 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000522085 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| Frame-shift | ENST00000522085 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5CDS-intron | ENST00000522085 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5UTR-3CDS | ENST00000518561 | ENST00000415757 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5UTR-3CDS | ENST00000518561 | ENST00000389232 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
| 5UTR-intron | ENST00000518561 | ENST00000559917 | LARP4 | chr12 | 50794811 | + | RYR3 | chr15 | 34028436 | + |
Top |
FusionProtFeatures for LARP4_RYR3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LARP4 | RYR3 |
| RNA binding protein that binds to the poly-A tract ofmRNA molecules (PubMed:21098120). Associates with the 40Sribosomal subunit and with polysomes (PubMed:21098120). Plays arole in the regulation of mRNA translation (PubMed:21098120).Plays a role in the regulation of cell morphology and cytoskeletalorganization (PubMed:21834987, PubMed:27615744).{ECO:0000269|PubMed:21098120, ECO:0000269|PubMed:21834987,ECO:0000269|PubMed:27615744}. | Calcium channel that mediates the release of Ca(2+) fromthe sarcoplasmic reticulum into the cytoplasm in muscle andthereby plays a role in triggering muscle contraction. Mayregulate Ca(2+) release by other calcium channels. Calcium channelthat mediates Ca(2+)-induced Ca(2+) release from the endoplasmicreticulum in non-muscle cells. Contributes to cellular calcium ionhomeostasis (By similarity). Plays a role in cellular calciumsignaling. {ECO:0000250, ECO:0000269|PubMed:12354756}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LARP4_RYR3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LARP4_RYR3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| LARP4 | ELAVL1, SIRT7, CUL3, COPS6, APP, MPG, TARDBP, LIN28A, LIN28B, CRX, BHLHE40, EGFR, GNB2L1, NTRK1, MYO1C, NPM1, RPL10, AKAP1, RNF126, G3BP1 | RYR3 | RYR2, FKBP1A, CUL1, CFTR, HNF1A, BMI1, FKBP1B |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LARP4_RYR3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LARP4_RYR3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | LARP4 | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|